ID   MK08_HUMAN              Reviewed;         427 AA.
AC   P45983; B5BTZ5; B7ZLV4; Q15709; Q15712; Q15713;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   05-OCT-2010, entry version 122.
DE   RecName: Full=Mitogen-activated protein kinase 8;
DE            Short=MAP kinase 8;
DE            Short=MAPK 8;
DE            EC=2.7.11.24;
DE   AltName: Full=JNK-46;
DE   AltName: Full=Stress-activated protein kinase 1;
DE   AltName: Full=Stress-activated protein kinase JNK1;
DE   AltName: Full=c-Jun N-terminal kinase 1;
GN   Name=MAPK8; Synonyms=JNK1, PRKM8, SAPK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fetal brain;
RX   MEDLINE=94185163; PubMed=8137421; DOI=10.1016/0092-8674(94)90380-8;
RA   Derijard B., Hibi M., Wu I.-H., Barrett T., Su B., Deng T., Karin M.,
RA   Davis R.J.;
RT   "JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds
RT   and phosphorylates the c-Jun activation domain.";
RL   Cell 76:1025-1037(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND ALTERNATIVE SPLICING.
RC   TISSUE=Brain;
RX   MEDLINE=96256293; PubMed=8654373;
RA   Gupta S., Barrett T., Whitmarsh A.J., Cavanagh J., Sluss H.K.,
RA   Derijard B., Davis R.J.;
RT   "Selective interaction of JNK protein kinase isoforms with
RT   transcription factors.";
RL   EMBO J. 15:2760-2770(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=19054851; DOI=10.1038/nmeth.1273;
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA   Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA   Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H.,
RA   Maruyama Y., Matsuo K., Minami K., Mitsubori M., Mori M.,
RA   Morishita R., Murase A., Nishikawa A., Nishikawa S., Okamoto T.,
RA   Sakagami N., Sakamoto Y., Sasaki Y., Seki T., Sono S., Sugiyama A.,
RA   Sumiya T., Takayama T., Takayama Y., Takeda H., Togashi T., Yahata K.,
RA   Yamada H., Yanagisawa Y., Endo Y., Imamoto F., Kisu Y., Tanaka S.,
RA   Isogai T., Imai J., Watanabe S., Nomura N.;
RT   "Human protein factory for converting the transcriptome into an in
RT   vitro-expressed proteome.";
RL   Nat. Methods 5:1011-1017(2008).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   MUTAGENESIS.
RX   MEDLINE=95141073; PubMed=7839144; DOI=10.1126/science.7839144;
RA   Derijard B., Raingeaud J., Barrett T., Wu I.-H., Han J.,
RA   Ulevitch R.J., Davis R.J.;
RT   "Independent human MAP-kinase signal transduction pathways defined by
RT   MEK and MKK isoforms.";
RL   Science 267:682-685(1995).
RN   [7]
RP   REGULATION BY MAP2K4 AND MAP2K7, AND COFACTOR.
RX   MEDLINE=20517265; PubMed=11062067; DOI=10.1042/0264-6021:3520145;
RA   Fleming Y., Armstrong C.G., Morrice N., Paterson A., Goedert M.,
RA   Cohen P.;
RT   "Synergistic activation of stress-activated protein kinase 1/c-Jun N-
RT   terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein
RT   kinase kinase 4 (MKK4) and MKK7.";
RL   Biochem. J. 352:145-154(2000).
RN   [8]
RP   INTERACTION WITH MECOM.
RX   PubMed=10856240; DOI=10.1093/emboj/19.12.2958;
RA   Kurokawa M., Mitani K., Yamagata T., Takahashi T., Izutsu K.,
RA   Ogawa S., Moriguchi T., Nishida E., Yazaki Y., Hirai H.;
RT   "The evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents
RT   stress-induced cell death.";
RL   EMBO J. 19:2958-2968(2000).
RN   [9]
RP   INTERACTION WITH WWOX AND TP53.
RX   PubMed=12514174; DOI=10.1074/jbc.M208373200;
RA   Chang N.-S., Doherty J., Ensign A.;
RT   "JNK1 physically interacts with WW domain-containing oxidoreductase
RT   (WOX1) and inhibits WOX1-mediated apoptosis.";
RL   J. Biol. Chem. 278:9195-9202(2003).
RN   [10]
RP   INTERACTION WITH SPAG9.
RX   PubMed=15693750; DOI=10.1042/BJ20041577;
RA   Jagadish N., Rana R., Selvi R., Mishra D., Garg M., Yadav S.,
RA   Herr J.C., Okumura K., Hasegawa A., Koyama K., Suri A.;
RT   "Characterization of a novel human sperm-associated antigen 9 (SPAG9)
RT   having structural homology with c-Jun N-terminal kinase-interacting
RT   protein.";
RL   Biochem. J. 389:73-82(2005).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH HSF4.
RX   PubMed=16581800; DOI=10.1128/MCB.26.8.3282-3294.2006;
RA   Hu Y., Mivechi N.F.;
RT   "Association and regulation of heat shock transcription factor 4b with
RT   both extracellular signal-regulated kinase mitogen-activated protein
RT   kinase and dual-specificity tyrosine phosphatase DUSP26.";
RL   Mol. Cell. Biol. 26:3282-3294(2006).
RN   [12]
RP   INTERACTION WITH NFATC4.
RX   PubMed=17875713; DOI=10.1158/0008-5472.CAN-06-4788;
RA   Yao K., Cho Y.-Y., Bergen H.R. III, Madden B.J., Choi B.Y., Ma W.-Y.,
RA   Bode A.M., Dong Z.;
RT   "Nuclear factor of activated T3 is a negative regulator of Ras-JNK1/2-
RT   AP-1 induced cell transformation.";
RL   Cancer Res. 67:8725-8735(2007).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-185, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-255; THR-258; TYR-259;
RP   TYR-357 AND THR-367, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-183 AND TYR-185, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [16]
RP   FUNCTION IN PHOSPHORYLATION OF JDP2.
RX   PubMed=18307971; DOI=10.1016/j.ab.2008.01.038;
RA   Murata T., Shinozuka Y., Obata Y., Yokoyama K.K.;
RT   "Phosphorylation of two eukaryotic transcription factors, Jun
RT   dimerization protein 2 and activation transcription factor 2, in
RT   Escherichia coli by Jun N-terminal kinase 1.";
RL   Anal. Biochem. 376:115-121(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-377, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-183; TYR-185 AND
RP   SER-377, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-185, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=19534553; DOI=10.1021/pr900044c;
RA   Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,
RA   Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,
RA   Wiley H.S., Qian W.-J.;
RT   "An extensive survey of tyrosine phosphorylation revealing new sites
RT   in human mammary epithelial cells.";
RL   J. Proteome Res. 8:3852-3861(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-155; THR-183; TYR-185
RP   AND SER-377, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-183 AND TYR-185, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [22]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-308, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [23]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-171 AND ARG-177.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Responds to activation by environmental stress and pro-
CC       inflammatory cytokines by phosphorylating a number of
CC       transcription factors, primarily components of AP-1 such as JUN,
CC       JDP2 and ATF2 and thus regulates AP-1 transcriptional activity. In
CC       T-cells, JNK1 and JNK2 are required for polarized differentiation
CC       of T-helper cells into Th1 cells (By similarity). Phosphorylates
CC       heat shock factor protein 4 (HSF4).
CC   -!- FUNCTION: JNK1 isoforms display different binding patterns: beta-1
CC       preferentially binds to c-Jun, whereas alpha-1, alpha-2, and beta-
CC       2 have a similar low level of binding to both c-Jun or ATF2.
CC       However, there is no correlation between binding and
CC       phosphorylation, which is achieved at about the same efficiency by
CC       all isoforms.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Activated by threonine and tyrosine
CC       phosphorylation by either of two dual specificity kinases, MAP2K4
CC       and MAP2K7. Inhibited by dual specificity phosphatases, such as
CC       DUSP1.
CC   -!- SUBUNIT: Binds to at least four scaffolding proteins,
CC       MAPK8IP1/JIP-1, MAPK8IP2/JIP-2, MAPK8IP3/JIP-3/JSAP1 and
CC       SPAG9/MAPK8IP4/JIP-4. These proteins also bind other components of
CC       the JNK signaling pathway. Interacts with TP53 and WWOX. Interacts
CC       with JAMP. Forms a complex with MAPK8IP1 and RGNEF (By
CC       similarity). Interacts (phosphorylated form) with NFE2; the
CC       interaction phosphorylates NFE2 in undifferentiated cells (By
CC       similarity). Interacts with NFATC4. Interacts with MECOM;
CC       regulates JNK signaling.
CC   -!- INTERACTION:
CC       P15336:ATF2; NbExp=1; IntAct=EBI-286483, EBI-1170906;
CC       P05412:JUN; NbExp=4; IntAct=EBI-286483, EBI-852823;
CC       P45985:MAP2K4; NbExp=1; IntAct=EBI-286483, EBI-447868;
CC       O14733:MAP2K7; NbExp=2; IntAct=EBI-286483, EBI-492605;
CC       Q9WVI9:Mapk8ip1 (xeno); NbExp=1; IntAct=EBI-286483, EBI-74515;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=2; Synonyms=JNK1-alpha-2;
CC         IsoId=P45983-1; Sequence=Displayed;
CC       Name=1; Synonyms=JNK1-alpha-1;
CC         IsoId=P45983-2; Sequence=VSP_004833;
CC       Name=3; Synonyms=JNK1-beta-1;
CC         IsoId=P45983-3; Sequence=VSP_004831, VSP_004832, VSP_004833;
CC       Name=4; Synonyms=JNK1-beta-2;
CC         IsoId=P45983-4; Sequence=VSP_004831, VSP_004832;
CC   -!- DOMAIN: The TXY motif contains the threonine and tyrosine residues
CC       whose phosphorylation activates the MAP kinases.
CC   -!- PTM: Dually phosphorylated on Thr-183 and Tyr-185, which activates
CC       the enzyme.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. MAP kinase subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/JNK1ID196.html";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=C-Jun N-terminal kinases entry;
CC       URL="http://en.wikipedia.org/wiki/C-Jun_N-terminal_kinases";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L26318; AAA36131.1; -; mRNA.
DR   EMBL; U34822; AAC50607.1; -; mRNA.
DR   EMBL; U35004; AAC50610.1; -; mRNA.
DR   EMBL; U35005; AAC50611.1; -; mRNA.
DR   EMBL; AB451231; BAG70045.1; -; mRNA.
DR   EMBL; CH471187; EAW93132.1; -; Genomic_DNA.
DR   EMBL; BC144063; AAI44064.1; -; mRNA.
DR   IPI; IPI00003145; -.
DR   IPI; IPI00024672; -.
DR   IPI; IPI00220305; -.
DR   IPI; IPI00220306; -.
DR   PIR; S71097; S71097.
DR   PIR; S71099; S71099.
DR   RefSeq; NP_002741.1; -.
DR   RefSeq; NP_620634.1; -.
DR   RefSeq; NP_620635.1; -.
DR   RefSeq; NP_620637.1; -.
DR   UniGene; Hs.138211; -.
DR   PDB; 1UKH; X-ray; 2.35 A; A=1-363.
DR   PDB; 1UKI; X-ray; 2.70 A; A=1-363.
DR   PDB; 2G01; X-ray; 3.50 A; A/B=1-364.
DR   PDB; 2GMX; X-ray; 3.50 A; A/B=1-364.
DR   PDB; 2H96; X-ray; 3.00 A; A/B=1-364.
DR   PDB; 2NO3; X-ray; 3.20 A; A/B=1-364.
DR   PDB; 3ELJ; X-ray; 1.80 A; A=1-364.
DR   PDBsum; 1UKH; -.
DR   PDBsum; 1UKI; -.
DR   PDBsum; 2G01; -.
DR   PDBsum; 2GMX; -.
DR   PDBsum; 2H96; -.
DR   PDBsum; 2NO3; -.
DR   PDBsum; 3ELJ; -.
DR   ProteinModelPortal; P45983; -.
DR   DIP; DIP-249N; -.
DR   IntAct; P45983; 36.
DR   MINT; MINT-1211982; -.
DR   STRING; P45983; -.
DR   PhosphoSite; P45983; -.
DR   PRIDE; P45983; -.
DR   Ensembl; ENST00000360332; ENSP00000353483; ENSG00000107643.
DR   Ensembl; ENST00000374179; ENSP00000363294; ENSG00000107643.
DR   Ensembl; ENST00000374189; ENSP00000363304; ENSG00000107643.
DR   GeneID; 5599; -.
DR   KEGG; hsa:5599; -.
DR   NMPDR; fig|9606.3.peg.3911; -.
DR   UCSC; uc001jgl.1; human.
DR   UCSC; uc001jgm.1; human.
DR   UCSC; uc001jgp.1; human.
DR   UCSC; uc001jgq.1; human.
DR   CTD; 5599; -.
DR   GeneCards; GC10P049514; -.
DR   HGNC; HGNC:6881; MAPK8.
DR   HPA; CAB004463; -.
DR   MIM; 601158; gene.
DR   PharmGKB; PA283; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG014652; -.
DR   InParanoid; P45983; -.
DR   OMA; TFTILKR; -.
DR   PhylomeDB; P45983; -.
DR   BRENDA; 2.7.11.24; 247.
DR   Pathway_Interaction_DB; angiopoietinreceptor_pathway; Angiopoietin receptor Tie2-mediated signaling.
DR   Pathway_Interaction_DB; bcr_5pathway; BCR signaling pathway.
DR   Pathway_Interaction_DB; ceramidepathway; Ceramide signaling pathway.
DR   Pathway_Interaction_DB; cd8tcrdownstreampathway; Downstream signaling in naive CD8+ T cells.
DR   Pathway_Interaction_DB; endothelinpathway; Endothelins.
DR   Pathway_Interaction_DB; ephrinbrevpathway; Ephrin B reverse signaling.
DR   Pathway_Interaction_DB; epopathway; EPO signaling pathway.
DR   Pathway_Interaction_DB; faspathway; FAS signaling pathway (CD95).
DR   Pathway_Interaction_DB; fcer1pathway; Fc-epsilon receptor I signaling in mast cells.
DR   Pathway_Interaction_DB; foxopathway; FoxO family signaling.
DR   Pathway_Interaction_DB; glypican_3pathway; Glypican 3 network.
DR   Pathway_Interaction_DB; hivnefpathway; HIV-1 Nef: Negative effector of Fas and TNF-alpha.
DR   Pathway_Interaction_DB; il1pathway; IL1-mediated signaling events.
DR   Pathway_Interaction_DB; il12_stat4pathway; IL12 signaling mediated by STAT4.
DR   Pathway_Interaction_DB; il2_1pathway; IL2-mediated signaling events.
DR   Pathway_Interaction_DB; tcrjnkpathway; JNK signaling in the CD4+ TCR pathway.
DR   Pathway_Interaction_DB; avb3_opn_pathway; Osteopontin-mediated events.
DR   Pathway_Interaction_DB; p75ntrpathway; p75(NTR)-mediated signaling.
DR   Pathway_Interaction_DB; reelinpathway; Reelin signaling pathway.
DR   Pathway_Interaction_DB; ar_tf_pathway; Regulation of Androgen receptor activity.
DR   Pathway_Interaction_DB; retinoic_acid_pathway; Retinoic acid receptors-mediated signaling.
DR   Pathway_Interaction_DB; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes.
DR   Pathway_Interaction_DB; s1p_s1p2_pathway; S1P2 pathway.
DR   Pathway_Interaction_DB; met_pathway; Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met).
DR   Pathway_Interaction_DB; kitpathway; Signaling events mediated by Stem cell factor receptor (c-Kit).
DR   Pathway_Interaction_DB; ret_pathway; Signaling events regulated by Ret tyrosine kinase.
DR   Pathway_Interaction_DB; syndecan_2_pathway; Syndecan-2-mediated signaling events.
DR   Pathway_Interaction_DB; trail_pathway; TRAIL signaling pathway.
DR   Reactome; REACT_11061; Signalling by NGF.
DR   Reactome; REACT_578; Apoptosis.
DR   Reactome; REACT_6900; Signaling in Immune system.
DR   NextBio; 21738; -.
DR   ArrayExpress; P45983; -.
DR   Bgee; P45983; -.
DR   CleanEx; HS_MAPK8; -.
DR   Genevestigator; P45983; -.
DR   GermOnline; ENSG00000107643; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004705; F:JUN kinase activity; IDA:UniProtKB.
DR   GO; GO:0005515; F:protein binding; IPI:UniProtKB.
DR   GO; GO:0008633; P:activation of pro-apoptotic gene products; EXP:Reactome.
DR   GO; GO:0043066; P:negative regulation of apoptosis; IDA:MGI.
DR   GO; GO:0009411; P:response to UV; IDA:MGI.
DR   InterPro; IPR008351; JNK_MAPK.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR003527; MAP_kinase_CS.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   PRINTS; PR01772; JNKMAPKINASE.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS01351; MAPK; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Kinase; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    427       Mitogen-activated protein kinase 8.
FT                                /FTId=PRO_0000186262.
FT   DOMAIN       26    321       Protein kinase.
FT   NP_BIND      32     40       ATP (By similarity).
FT   MOTIF       183    185       TXY.
FT   ACT_SITE    151    151       Proton acceptor (By similarity).
FT   BINDING      55     55       ATP (By similarity).
FT   MOD_RES     155    155       Phosphoserine.
FT   MOD_RES     183    183       Phosphothreonine.
FT   MOD_RES     185    185       Phosphotyrosine.
FT   MOD_RES     255    255       Phosphothreonine.
FT   MOD_RES     258    258       Phosphothreonine.
FT   MOD_RES     259    259       Phosphotyrosine.
FT   MOD_RES     308    308       N6-acetyllysine.
FT   MOD_RES     357    357       Phosphotyrosine.
FT   MOD_RES     367    367       Phosphothreonine.
FT   MOD_RES     377    377       Phosphoserine.
FT   VAR_SEQ     208    208       L -> I (in isoform 3 and isoform 4).
FT                                /FTId=VSP_004831.
FT   VAR_SEQ     219    230       VCHKILFPGRDY -> IKGGVLFPGTDH (in isoform
FT                                3 and isoform 4).
FT                                /FTId=VSP_004832.
FT   VAR_SEQ     380    427       GAAVINGSQHPSSSSSVNDVSSMSTDPTLASDTDSSLEAAA
FT                                GPLGCCR -> AQVQQ (in isoform 1 and
FT                                isoform 3).
FT                                /FTId=VSP_004833.
FT   VARIANT     171    171       G -> S (in a renal clear cell carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_042258.
FT   VARIANT     177    177       G -> R (in a glioblastoma multiforme
FT                                sample; somatic mutation).
FT                                /FTId=VAR_042259.
FT   VARIANT     365    365       E -> K (in dbSNP:rs45483593).
FT                                /FTId=VAR_050592.
FT   MUTAGEN     183    183       T->A: Phosphorylation blocked.
FT   MUTAGEN     185    185       Y->F: Phosphorylation blocked.
FT   STRAND       10     15
FT   STRAND       18     23
FT   STRAND       26     45
FT   TURN         46     49
FT   STRAND       50     59
FT   HELIX        64     79
FT   STRAND       88     92
FT   TURN         98    100
FT   STRAND      105    109
FT   STRAND      112    114
FT   HELIX       115    118
FT   HELIX       125    143
FT   TURN        144    146
FT   TURN        154    156
FT   STRAND      157    159
FT   STRAND      165    167
FT   HELIX       194    197
FT   HELIX       206    220
FT   HELIX       230    241
FT   HELIX       246    250
FT   HELIX       254    260
FT   HELIX       271    274
FT   HELIX       277    279
FT   HELIX       288    301
FT   HELIX       306    308
FT   HELIX       312    317
FT   TURN        319    321
FT   HELIX       322    324
FT   HELIX       327    330
FT   HELIX       351    361
SQ   SEQUENCE   427 AA;  48296 MW;  94FB6BE0358B9B60 CRC64;
     MSRSKRDNNF YSVEIGDSTF TVLKRYQNLK PIGSGAQGIV CAAYDAILER NVAIKKLSRP
     FQNQTHAKRA YRELVLMKCV NHKNIIGLLN VFTPQKSLEE FQDVYIVMEL MDANLCQVIQ
     MELDHERMSY LLYQMLCGIK HLHSAGIIHR DLKPSNIVVK SDCTLKILDF GLARTAGTSF
     MMTPYVVTRY YRAPEVILGM GYKENVDLWS VGCIMGEMVC HKILFPGRDY IDQWNKVIEQ
     LGTPCPEFMK KLQPTVRTYV ENRPKYAGYS FEKLFPDVLF PADSEHNKLK ASQARDLLSK
     MLVIDASKRI SVDEALQHPY INVWYDPSEA EAPPPKIPDK QLDEREHTIE EWKELIYKEV
     MDLEERTKNG VIRGQPSPLG AAVINGSQHP SSSSSVNDVS SMSTDPTLAS DTDSSLEAAA
     GPLGCCR
//
